Developer docs
API playgroundTry for free, no card

Search company profiles

Science&Humans

Full company profile

uuid0002gjr

Namestring
Science&Humans
Legal namestring
Science&Humans
Company typeenum
Private
Founded yearint
2024
Descriptiontext

Science&Humans is a Canadian digital hormone health platform headquartered in Mississauga, Ontario, founded in 2020 and operating across eight condition-specific programs spanning perimenopause and menopause, early reproductive hormone health (PCOS, PMS, PMDD, endometriosis, thyroid), weight optimization, prescription skincare, hair regrowth, male hormone replacement therapy, and erectile dysfunction. The company serves 60,000+ direct-to-consumer subscribers across Canada through a self-serve web and mobile platform, delivering virtual clinician-led consultations, integrated diagnostics, prescription treatments, and home delivery. Clinical leadership includes Chief Women's Health Advisor Dr. Kristy Prouse (OB/GYN, 30+ years), Chief Men's Health Advisor Dr. Fady Hannah-Shmouni (Clinical Professor of Endocrinology at UBC), and a bench of nurse practitioners specialized in hormone therapy. Operational scale includes 500,000+ prescriptions issued and 1M+ biomarkers tested.

The technology stack combines 20–40+ biomarker comprehensive diagnostics, virtual clinician consultations, prescription pharmacy services, and the Healthspan at-home capillary blood testing device — positioned as Canada's first consumer at-home hormone blood test, with results delivered within 2–3 days. A commercial agreement with SuperQ Quantum Computing targets deployment of hybrid quantum-classical AI clinician systems to enhance diagnostic and treatment processes, though no deployed AI products are disclosed. The company holds LegitScript certification and operates as a vertically integrated platform spanning diagnostics, telehealth, and pharmacy.

Science&Humans operates a subscription-based revenue model with quarterly recurring fees of $150–$200 per program plus prescription medication revenue (topicals, patches, oral therapy, injectable pens priced at $80–$450 per dispensing period). Go-to-market combines direct-to-consumer digital sales, direct B2B enterprise contracts with major Canadian insurance companies for employer-sponsored benefits, and channel partnerships through the Segic Benefits Marketplace for broker and plan-sponsor distribution. The company raised a $10 million oversubscribed Series A in January 2026, combining $7M equity led by Pender Ventures (with participation from WELL Health Technologies, Michele Romanow, and US-based family offices and clinicians) and $3M venture debt from CIBC Innovation Banking. Funding is earmarked to scale nationwide access and deepen employer and insurer partnerships.

Short descriptiontext

Science&Humans is a Canadian digital hormone health platform offering virtual clinician-led diagnosis, treatment, and prescription delivery across perimenopause, menopause, PCOS, low testosterone, and related conditions to 60,000+ DTC subscribers and B2B benefits customers nationwide.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersToronto, Canada
HQ citystring
Toronto
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
hormone replacement therapy, digital hormone health, virtual hormone clinic, menopause telehealth care, at-home hormone diagnostics
Industry1 code
PRIMARYHLALAAAE
At-Home Lab Testing & Diagnostics-Integrated Virtual Care
Healthcare & Life Sciences/Telehealth Platforms/Direct-to-Consumer Virtual Care Platforms
NAICS code2 codes
  • Medical and Diagnostic Laboratories62151
  • Offices of Physicians6211
SIC code2 codes
  • Services-Medical Laboratories8071
  • Services-Offices & Clinics Of Doctors Of Medicine8011
Product category
Digital Hormone Health / Telehealth Endocrinology Services
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1Subscription Recurring (DTC)
TypeSubscription Recurring
Description

Quarterly subscription model for direct-to-consumer hormone health programs including unlimited access to care team, virtual consultations, lab monitoring, and prescription management. Programs include Perimenopause & Menopause ($200/quarter ongoing), Early Reproductive Health ($150/quarter), Men's Hormone Health ($200/quarter), and Weight Optimization.

bnnbloomberg.ca
2Clinical Consultation Fees
TypeSubscription Recurring
Description

One-time clinician consultation fees charged at initial assessment ($50-$200 depending on program) with quarterly follow-up consultations included in subscription.

newswire.ca
3Prescription Medications
TypeSubscription Recurring
Description

Prescription treatments including topical creams ($80-$200/3 months), patches ($150-$250/3 months), oral therapy ($100-$200/3 months), injectable pens ($250-$450/month), and supplements ($20-$67/month) delivered through integrated pharmacy services.

scienceandhumans.com
4B2B Enterprise / Employer Benefits
TypeSubscription Recurring
Description

Enterprise contracts with employers, insurers, and benefits providers to provide hormone health programs as part of employee benefits packages through partnerships like the Segic Benefits Marketplace.

aijourn.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components1 value
Personnel
Pricing details7 tiers
1Perimenopause & Menopause Program
ModelSubscriptionBilling cadenceQuarterly
Notes

$50 initial bloodwork + $200 clinician consultation. Ongoing care $200/quarter. Treatments: Topical cream $150-$200/3 months, Patches $150-$250/3 months, Oral therapy $100-$200/3 months, Vaginal therapy $80-$150/3 months, Thyroid treatment $100-$200/3 months, Hair regrowth $100-$200/3 months, Non-hormonal $100-$200/3 months.

scienceandhumans.com
2Early Reproductive Hormone Health Program
ModelSubscriptionBilling cadenceMonthly
Notes

Cycle regulation therapy $50-$85/month, Metabolic optimization $50-$100/month, Anti-inflammatory therapy $50-$85/month, Thyroid optimization $35-$67/month, Fertility treatments vary, Non-hormonal therapy $35-$67/month.

scienceandhumans.com
3Weight Optimization Program
ModelSubscriptionBilling cadenceMonthly
Notes

$100 clinician consultation (30-min). Injectable pen ~$250-$450/month, Oral pills ~$300/month. Not typically covered by insurance.

scienceandhumans.com
4Men's Hormone Health Program
ModelSubscriptionBilling cadenceQuarterly
Notes

$150 clinician consultation + $200/quarter ongoing care. Hormone injections $60-$90/vial, Monotherapy ~$100/vial, Topical creams/gels ~$100-$125/month, Oral therapy ~$100/month, Supplements ~$20-$50/month.

scienceandhumans.com
5Prescription Skincare Program
ModelSubscriptionBilling cadenceMonthly
Notes

$25 assessment. Prescription-grade hormonal skin cream ~$60/30-day supply. Auto-refills every 3 months via pharmacy ($10 shipping).

scienceandhumans.com
6Hair Regrowth Treatment
ModelSubscriptionBilling cadenceMonthly
Notes

Topical solution ~$40/30-day supply. Results typically 3-6 months. 3-month prescription deliveries.

scienceandhumans.com
7Erectile Dysfunction Treatment
ModelSubscriptionBilling cadenceMonthly
Notes

Pricing not publicly disclosed on main website pages.

scienceandhumans.com
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Brand1 record
1Healthspan
Description

Canada's first at-home blood test device for hormone biomarker testing, providing convenient at-home diagnostic testing with results delivered within 2-3 days.

scienceandhumans.com
Core offering1 text field

Science&Humans is a Canadian digital hormone health platform that delivers virtual, clinician-led hormone care programs for women and men. It combines at-home blood diagnostics, comprehensive biomarker testing (20-40+ biomarkers), telehealth consultations with nurse practitioners and physicians, personalized prescription treatment plans (BHRT, TRT, weight optimization medications, prescription skincare, hair regrowth), and direct-to-door medication delivery through an integrated pharmacy. Programs are sold as recurring subscriptions and also distributed through employer benefits marketplaces and insurance partnerships.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 9 values shown
  • 88% of S&H patients report symptom improvement in 90 days
+8 more records
Product overview1 text field

Science&Humans is a digital hormone health platform offering a comprehensive suite of virtual, clinician-led hormone health programs for both women and men. The platform operates as a modular care ecosystem combining at-home diagnostics (Healthspan), virtual consultations, and personalized treatment plans across multiple condition-specific programs. Women's offerings include Perimenopause & Menopause Treatment, Early Reproductive Hormone Health Program (PCOS, PMS, PMDD, Endometriosis), Weight Optimization, Prescription Skincare, and Hair Regrowth. Men's offerings include Hormone Replacement Therapy (TRT), Weight Optimization, Erectile Dysfunction Treatment, and Hair Regrowth. All programs feature comprehensive biomarker testing (20-40+ biomarkers), unlimited access to care teams, prescription management, and health coaching support.

Product and service8 records
1Perimenopause & Menopause Treatment
CategoryWomen's Hormone Health
Description

Virtual clinician-led Bioidentical Hormone Replacement Therapy (BHRT) program for women in midlife, including 40+ biomarker diagnostics, personalized care plans, and treatments such as topical creams, patches, oral therapy, vaginal therapy, thyroid treatment, arousal treatment, hair regrowth, facial anti-aging, and non-hormonal options.

2Early Reproductive Hormone Health Program
CategoryWomen's Hormone Health
Description

Expert-led hormone and metabolic optimization program for women with PCOS, PMS, PMDD, endometriosis, thyroid conditions, and infertility. Includes cycle regulation therapy, metabolic and insulin optimization, anti-inflammatory hormone therapy, thyroid optimization, fertility optimization treatments, and non-hormonal precision therapy.

3Weight Optimization Program
CategoryMedical Weight Management
Description

Medical weight optimization program with 20+ biomarker testing, personalized treatment plans including injectable pens and oral medications for appetite regulation and metabolic balance, and comprehensive lifestyle coaching. Offered for both men and women.

4Prescription Skincare Program
CategoryHormonal Skincare
Description

Prescription-grade hormonal skin cream (Estriol 0.3%) for midlife skin concerns including hydration, texture, tone, and elasticity. Includes prescription issuance and automatic refills via licensed pharmacy every 3 months.

5Hair Regrowth Treatment for Women
CategoryHair Restoration
Description

Topical prescription hair regrowth solution for women to slow hormonal hair thinning, promote regrowth, and reduce DHT, delivered every 3 months.

6Male Hormone Replacement Therapy (Hormone Health)
CategoryMen's Hormone Health
Description

Clinician-led Hormone Replacement Therapy for men with 40+ biomarker testing. Treatments include hormone injections, monotherapy, topical creams/gels, oral therapy, and supplements targeting testosterone deficiency, andropause, and age-related hormonal decline.

7Erectile Dysfunction Treatment
CategoryMen's Sexual Health
Description

Prescription treatments for erectile dysfunction delivered discreetly through a virtual care platform with personalized treatment plans and ongoing clinician support.

8Hair Regrowth Treatment for Men
CategoryHair Restoration
Description

Prescription hair regrowth treatments for men to reduce shedding and regrow hair, offered as part of the men's hormone health program.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeGTM or Marketing PartnerAnnounced on2026-06-05
Description

Quebec-based employee benefits technology company. Science&Humans integrates its full suite of virtual, clinician-led hormone health programs into the Segic Benefits Marketplace, enabling employers, brokers, and plan sponsors to offer specialized hormone health services through a digital platform.

Strategic tierStrategicTypeTechnology or IntegrationAnnounced on2025-11-04
Description

Commercial agreement to deploy quantum-AI clinician systems in healthcare workflows. Collaboration aims to enhance diagnostic and treatment processes using hybrid quantum-classical computing, targeting high accuracy and reliability in sensitive medical applications.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Telehealth clinic focused on thyroid and hormone-related conditions for women and men. Comparable in condition-specific virtual care model, at-home lab integration, and clinician-led hormone management approach.

TypeEmerging player
Description

Virtual care platform for women's and family health, including fertility, postpartum, and menopause support with employer/benefits distribution. Comparable in women's virtual care focus and B2B benefits motion.

3Ro (Roman Health)
TypeBroad incumbent
Description

Multi-condition DTC telehealth including men's testosterone replacement, weight management, and women's health. Comparable to Science&Humans across men's TRT and weight programs, though with a much broader portfolio.

TypeDirect peer
Description

Telehealth platform for women in menopause offering prescription hormone therapy and ongoing clinician support. Directly comparable to Science&Humans' perimenopause/menopause program in product and audience.

TypeDirect peer
Description

Direct-to-consumer telehealth specializing in hormone replacement therapy for women in menopause. Overlaps directly with Science&Humans' perimenopause/menopause program, including online consultations and prescription delivery.

TypeEmerging player
Description

Virtual care platform for substance use, mental health, and chronic conditions, primarily distributed through employer benefits. Comparable in B2B enterprise/employer benefits distribution motion that Science&Humans is building.

TypeDirect peer
Description

Direct-to-consumer telehealth focused exclusively on men's testosterone replacement therapy. Comparable to Science&Humans' men's hormone program in clinical model, pricing structure, and target demographic.

TypeDirect peer
Description

U.S.-based virtual care clinic focused on perimenopause and menopause for women. Closest analog to Science&Humans' women's midlife hormone program, with similar clinician-led BHRT model and enterprise/employer distribution focus.

TypeDirect peer
Description

Virtual menopause care platform offering clinician consultations and hormone therapy prescriptions. Comparable in target demographic (women 40+), care delivery model, and condition-specific positioning.

TypeBroad incumbent
Description

Large publicly traded DTC telehealth platform spanning men's and women's health, including testosterone therapy, menopause support, and weight loss. Competes with Science&Humans across multiple product lines but at vastly larger scale and broader scope.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors4 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Science&Humans

Digital Hormone Health / Telehealth Endocrinology Servicesscienceandhumans.com

Science&Humans is a Canadian digital hormone health platform offering virtual clinician-led diagnosis, treatment, and prescription delivery across perimenopause, menopause, PCOS, low testosterone, and related conditions to 60,000+ DTC subscribers and B2B benefits customers nationwide.

What Science&Humans does

Science&Humans is a Canadian digital hormone health platform headquartered in Mississauga, Ontario, founded in 2020 and operating across eight condition-specific programs spanning perimenopause and menopause, early reproductive hormone health (PCOS, PMS, PMDD, endometriosis, thyroid), weight optimization, prescription skincare, hair regrowth, male hormone replacement therapy, and erectile dysfunction. The company serves 60,000+ direct-to-consumer subscribers across Canada through a self-serve web and mobile platform, delivering virtual clinician-led consultations, integrated diagnostics, prescription treatments, and home delivery. Clinical leadership includes Chief Women's Health Advisor Dr. Kristy Prouse (OB/GYN, 30+ years), Chief Men's Health Advisor Dr. Fady Hannah-Shmouni (Clinical Professor of Endocrinology at UBC), and a bench of nurse practitioners specialized in hormone therapy. Operational scale includes 500,000+ prescriptions issued and 1M+ biomarkers tested.

The technology stack combines 20–40+ biomarker comprehensive diagnostics, virtual clinician consultations, prescription pharmacy services, and the Healthspan at-home capillary blood testing device — positioned as Canada's first consumer at-home hormone blood test, with results delivered within 2–3 days. A commercial agreement with SuperQ Quantum Computing targets deployment of hybrid quantum-classical AI clinician systems to enhance diagnostic and treatment processes, though no deployed AI products are disclosed. The company holds LegitScript certification and operates as a vertically integrated platform spanning diagnostics, telehealth, and pharmacy.

Science&Humans operates a subscription-based revenue model with quarterly recurring fees of $150–$200 per program plus prescription medication revenue (topicals, patches, oral therapy, injectable pens priced at $80–$450 per dispensing period). Go-to-market combines direct-to-consumer digital sales, direct B2B enterprise contracts with major Canadian insurance companies for employer-sponsored benefits, and channel partnerships through the Segic Benefits Marketplace for broker and plan-sponsor distribution. The company raised a $10 million oversubscribed Series A in January 2026, combining $7M equity led by Pender Ventures (with participation from WELL Health Technologies, Michele Romanow, and US-based family offices and clinicians) and $3M venture debt from CIBC Innovation Banking. Funding is earmarked to scale nationwide access and deepen employer and insurer partnerships.

Science&Humans firmographics

Firmographics
Name
Science&Humans
Legal name
Science&Humans
Website
https://scienceandhumans.com
Company type
Private
Founded year
2024
Operating status
Operating
Headcount range
51–100 employees
Short description
Science&Humans is a Canadian digital hormone health platform offering virtual clinician-led diagnosis, treatment, and prescription delivery across perimenopause, menopause, PCOS, low testosterone, and related conditions to 60,000+ DTC subscribers and B2B benefits customers nationwide.
Ownership category
akta.pro rank

Science&Humans industry classification

Industry
Product category
Digital Hormone Health / Telehealth Endocrinology Services
NAICS
Medical and Diagnostic Laboratories (62151), Offices of Physicians (6211)
SIC
Services-Medical Laboratories (8071), Services-Offices & Clinics Of Doctors Of Medicine (8011)
akta.pro industry
PRIMARYHLALAAAE
At-Home Lab Testing & Diagnostics-Integrated Virtual Care
Healthcare & Life Sciences/Telehealth Platforms/Direct-to-Consumer Virtual Care Platforms

Keywords

  • Hormone replacement therapy
  • Digital hormone health
  • Virtual hormone clinic
  • Menopause telehealth care
  • At-home hormone diagnostics

Where Science&Humans is headquartered

Location

Headquarters

HQ city
Toronto
HQ country
Canada
HQ region
North America

Offices2 records

Markets served

Science&Humans business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel

Revenue model

  1. Subscription Recurring (DTC): Quarterly subscription model for direct-to-consumer hormone health programs including unlimited access to care team, virtual consultations, lab monitoring, and prescription management. Programs include Perimenopause & Menopause ($200/quarter ongoing), Early Reproductive Health ($150/quarter), Men's Hormone Health ($200/quarter), and Weight Optimization.
  2. Clinical Consultation Fees: One-time clinician consultation fees charged at initial assessment ($50-$200 depending on program) with quarterly follow-up consultations included in subscription.
  3. Prescription Medications: Prescription treatments including topical creams ($80-$200/3 months), patches ($150-$250/3 months), oral therapy ($100-$200/3 months), injectable pens ($250-$450/month), and supplements ($20-$67/month) delivered through integrated pharmacy services.
  4. B2B Enterprise / Employer Benefits: Enterprise contracts with employers, insurers, and benefits providers to provide hormone health programs as part of employee benefits packages through partnerships like the Segic Benefits Marketplace.

Pricing tiers

ModelBillingPrice
SubscriptionQuarterlyPerimenopause & Menopause Program
SubscriptionMonthlyEarly Reproductive Hormone Health Program
SubscriptionMonthlyWeight Optimization Program
SubscriptionQuarterlyMen's Hormone Health Program
SubscriptionMonthlyPrescription Skincare Program
SubscriptionMonthlyHair Regrowth Treatment
SubscriptionMonthlyErectile Dysfunction Treatment

Go-to-market motion3 records

Distribution channels4 records

Marketing channels6 records

Science&Humans product offering

Product offering

Core offering

Science&Humans is a Canadian digital hormone health platform that delivers virtual, clinician-led hormone care programs for women and men. It combines at-home blood diagnostics, comprehensive biomarker testing (20-40+ biomarkers), telehealth consultations with nurse practitioners and physicians, personalized prescription treatment plans (BHRT, TRT, weight optimization medications, prescription skincare, hair regrowth), and direct-to-door medication delivery through an integrated pharmacy. Programs are sold as recurring subscriptions and also distributed through employer benefits marketplaces and insurance partnerships.

Product overview

Science&Humans is a digital hormone health platform offering a comprehensive suite of virtual, clinician-led hormone health programs for both women and men. The platform operates as a modular care ecosystem combining at-home diagnostics (Healthspan), virtual consultations, and personalized treatment plans across multiple condition-specific programs. Women's offerings include Perimenopause & Menopause Treatment, Early Reproductive Hormone Health Program (PCOS, PMS, PMDD, Endometriosis), Weight Optimization, Prescription Skincare, and Hair Regrowth. Men's offerings include Hormone Replacement Therapy (TRT), Weight Optimization, Erectile Dysfunction Treatment, and Hair Regrowth. All programs feature comprehensive biomarker testing (20-40+ biomarkers), unlimited access to care teams, prescription management, and health coaching support.

Differentiator

Problem solved

Functional benefit

Brands

  • Healthspan: Canada's first at-home blood test device for hormone biomarker testing, providing convenient at-home diagnostic testing with results delivered within 2-3 days.

Products and services

  • Perimenopause & Menopause Treatment Virtual clinician-led Bioidentical Hormone Replacement Therapy (BHRT) program for women in midlife, including 40+ biomarker diagnostics, personalized care plans, and treatments such as topical creams, patches, oral therapy, vaginal therapy, thyroid treatment, arousal treatment, hair regrowth, facial anti-aging, and non-hormonal options.
  • Early Reproductive Hormone Health Program Expert-led hormone and metabolic optimization program for women with PCOS, PMS, PMDD, endometriosis, thyroid conditions, and infertility. Includes cycle regulation therapy, metabolic and insulin optimization, anti-inflammatory hormone therapy, thyroid optimization, fertility optimization treatments, and non-hormonal precision therapy.
  • Weight Optimization Program Medical weight optimization program with 20+ biomarker testing, personalized treatment plans including injectable pens and oral medications for appetite regulation and metabolic balance, and comprehensive lifestyle coaching. Offered for both men and women.
  • Prescription Skincare Program Prescription-grade hormonal skin cream (Estriol 0.3%) for midlife skin concerns including hydration, texture, tone, and elasticity. Includes prescription issuance and automatic refills via licensed pharmacy every 3 months.
  • Hair Regrowth Treatment for Women Topical prescription hair regrowth solution for women to slow hormonal hair thinning, promote regrowth, and reduce DHT, delivered every 3 months.
  • Male Hormone Replacement Therapy (Hormone Health) Clinician-led Hormone Replacement Therapy for men with 40+ biomarker testing. Treatments include hormone injections, monotherapy, topical creams/gels, oral therapy, and supplements targeting testosterone deficiency, andropause, and age-related hormonal decline.
  • Erectile Dysfunction Treatment Prescription treatments for erectile dysfunction delivered discreetly through a virtual care platform with personalized treatment plans and ongoing clinician support.
  • Hair Regrowth Treatment for Men Prescription hair regrowth treatments for men to reduce shedding and regrow hair, offered as part of the men's hormone health program.

Quantifiable outcome

  • 88% of S&H patients report symptom improvement in 90 days
  • +8 more outcomes

Companies that use Science&Humans

Customer profile

Named customers1 record

Segments5 records

Ideal customer profiles3 records

Science&Humans technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Science&Humans partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core and strategic.

  • SegiccoreGTM or Marketing Partner · 5 June 2026Quebec-based employee benefits technology company. Science&Humans integrates its full suite of virtual, clinician-led hormone health programs into the Segic Benefits Marketplace, enabling employers, brokers, and plan sponsors to offer specialized hormone health services through a digital platform.
  • SuperQ Quantum ComputingstrategicTechnology or Integration · 4 November 2025Commercial agreement to deploy quantum-AI clinician systems in healthcare workflows. Collaboration aims to enhance diagnostic and treatment processes using hybrid quantum-classical computing, targeting high accuracy and reliability in sensitive medical applications.

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

Science&Humans competitors and assessment

Company assessment

Direct peers

  • Paloma Health: Telehealth clinic focused on thyroid and hormone-related conditions for women and men. Comparable in condition-specific virtual care model, at-home lab integration, and clinician-led hormone management approach.
  • Alloy Women's Health: Telehealth platform for women in menopause offering prescription hormone therapy and ongoing clinician support. Directly comparable to Science&Humans' perimenopause/menopause program in product and audience.
  • Winona: Direct-to-consumer telehealth specializing in hormone replacement therapy for women in menopause. Overlaps directly with Science&Humans' perimenopause/menopause program, including online consultations and prescription delivery.
  • Fountain TRT: Direct-to-consumer telehealth focused exclusively on men's testosterone replacement therapy. Comparable to Science&Humans' men's hormone program in clinical model, pricing structure, and target demographic.
  • Midi Health: U.S.-based virtual care clinic focused on perimenopause and menopause for women. Closest analog to Science&Humans' women's midlife hormone program, with similar clinician-led BHRT model and enterprise/employer distribution focus.
  • Evernow: Virtual menopause care platform offering clinician consultations and hormone therapy prescriptions. Comparable in target demographic (women 40+), care delivery model, and condition-specific positioning.

Emerging players

  • Maven Clinic: Virtual care platform for women's and family health, including fertility, postpartum, and menopause support with employer/benefits distribution. Comparable in women's virtual care focus and B2B benefits motion.
  • Pelago Health: Virtual care platform for substance use, mental health, and chronic conditions, primarily distributed through employer benefits. Comparable in B2B enterprise/employer benefits distribution motion that Science&Humans is building.

Broad incumbents

  • Ro (Roman Health): Multi-condition DTC telehealth including men's testosterone replacement, weight management, and women's health. Comparable to Science&Humans across men's TRT and weight programs, though with a much broader portfolio.
  • Hims & Hers Health: Large publicly traded DTC telehealth platform spanning men's and women's health, including testosterone therapy, menopause support, and weight loss. Competes with Science&Humans across multiple product lines but at vastly larger scale and broader scope.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Science&Humans social profiles

Digital presence

Science&Humans compliance and trust

Trust signal

Compliance1 record

Science&Humans financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Science&Humans leadership team

Management profile

Number of profiles

Profiles5 records

Science&Humans funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Science&Humans M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Science&Humans

What does Science&Humans do?

Science&Humans is a Canadian digital hormone health platform that delivers virtual, clinician-led hormone care programs for women and men. It combines at-home blood diagnostics, comprehensive biomarker testing (20-40+ biomarkers), telehealth consultations with nurse practitioners and physicians, personalized prescription treatment plans (BHRT, TRT, weight optimization medications, prescription skincare, hair regrowth), and direct-to-door medication delivery through an integrated pharmacy. Programs are sold as recurring subscriptions and also distributed through employer benefits marketplaces and insurance partnerships.

Is Science&Humans a public or private company?

Science&Humans is a private company. It is classified as venture growth investor backed and is currently operating.

When was Science&Humans founded?

Science&Humans was founded in 2024. It employs 51 to 100 people.

Where is Science&Humans based?

Science&Humans is headquartered in Toronto, Canada, in the North America region.

How does Science&Humans make money?

Four revenue lines are on record. Subscription Recurring (DTC) is the primary driver. The others are clinical Consultation Fees, prescription Medications and B2B Enterprise / Employer Benefits.

Who are Science&Humans's main competitors?

Direct peers on record are Paloma Health, Alloy Women's Health, Winona, Fountain TRT, Midi Health and Evernow. Emerging players are Maven Clinic and Pelago Health. Broad incumbents are Ro (Roman Health) and Hims & Hers Health.

Does Science&Humans have an API?

No public API is recorded for Science&Humans.

What industry is Science&Humans in?

Science&Humans's product category is Digital Hormone Health / Telehealth Endocrinology Services. Its primary akta.pro industry code is HLALAAAE, At-Home Lab Testing & Diagnostics-Integrated Virtual Care. Its NAICS code is 62151 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
NewswireScience&Humans Partners with Frontier HSA to Expand Access to Specialized Hormone Health BenefitsScience&Humans partnered with Frontier HSA to add its clinician-led hormone health programs to the Frontier HSA benefits marketplace. The integration gives employers and members access to virtual care for conditions like PCOS, menopause, and metabolic health. The collaboration aims to provide earlier, proactive hormone and metabolic care.Financial PostScience&Humans Partners with Frontier HSA to Expand Access to Specialized Hormone Health BenefitsScience&Humans partnered with Frontier HSA to add its clinician-led hormone health programs to the Frontier HSA benefits marketplace. The programs cover perimenopause, menopause, metabolic health, and men's hormone care, delivered via a digital platform. The collaboration aims to give members earlier access to proactive hormone and metabolic care.BetaKitFor Canadian femtech, women’s autonomy is part of the business modelCanadian femtech startups are attracting venture capital as they address underserved women's health needs, with several companies announcing funding rounds including myStoria's $1.65M seed round, Coral's $4M CAD raise, June Health's $2.4M close, Science&Humans' $10M CAD round, and Flora Fertility's $5M USD seed round. The sector has grown from 51 to 200 companies in Canada, with investors like The51 launching funds indexed on the economic connection between women's health and workforce participation. Key growth areas include fertility tech, virtual healthcare platforms, hormone monitoring, and workplace benefits management.NewswireScience&Humans and Quikcard Launch National Hormone Health BenefitScience&Humans and Quikcard launched a clinician-led hormone health benefit for plan members across Canada, with coverage starting today. The program offers lab diagnostics, virtual consultations, and personalized treatment plans, addressing symptoms reported by about one in three adults and over 75% of menopausal women.Newswire/C O R R E C T I O N -- Science and Humans/Science&Humans launched Healthspan by Science&Humans, Canada's first at-home blood collection service for hormone testing. The service tests testosterone, free testosterone, SHBG, estradiol, and progesterone, with results sent within three business days. It is available in Ontario for $149, with an introductory $99 price for the first 3,000 buyers, and will expand across Canada by September 2026.AijournScience&Humans Partners with Segic to Expand Access to Specialized Hormone Health BenefitsScience&Humans, Canada's digital hormone health platform, announced a partnership with Segic, a Quebec-based employee benefits technology company, to expand access to its hormone health programs through Segic's Benefits Marketplace. The integration enables employers, brokers, and plan sponsors to incorporate Science&Humans' virtual, clinician-led hormone health services—including care for PMOS, menopause, metabolic health, and andropause—into their employee benefits offerings. This collaboration reflects growing demand for personalized healthcare solutions within employer-sponsored benefits and allows both companies to scale their respective platforms in the workplace wellness market.NewswireScience&Humans Partners with Segic to Expand Access to Specialized Hormone Health BenefitsScience&Humans, Canada's digital hormone health platform, announced a partnership with Quebec-based technology company Segic to integrate its full suite of virtual, clinician-led hormone health programs into the Segic Benefits Marketplace. The collaboration enables employers, brokers, and plan sponsors to offer specialized hormone health services, including care for conditions such as PCOS, PMDD, menopause, and metabolic health, through a digital platform combining diagnostics, virtual consultations, and personalized treatment plans. Industry leaders framed the partnership as part of the broader shift toward more personalized, outcome-driven healthcare within employer-sponsored benefits.YahooWho Am I? Nearly 6 in 10 Canadian Women Say Hormonal Changes Are Reshaping Their Sense of SelfA survey conducted by Leger reveals that nearly 6 in 10 Canadian women experience changes in their sense of identity due to hormonal fluctuations. The survey highlights the emotional and psychological impact of hormone health, with many women feeling unsupported and dismissed within the healthcare system. The campaign by Science&Humans aims to raise awareness and improve conversations about women's hormone health.NewswireWho Am I? Nearly 6 in 10 Canadian Women Say Hormonal Changes Are Reshaping Their Sense of SelfA Leger survey of 698 Canadian women found 59% say hormonal changes have impacted their sense of identity. The survey also found 52% faced barriers seeking hormone care, and 81% believe providers need better training. Science&Humans launched a campaign to address these gaps.Benefits Canada.com2026 Vancouver Benefits Summit: Why employers should invest in hormone healthJordan Tallis presented data at Benefits Canada's 2026 Vancouver Benefits Summit showing that while global life expectancy has increased 19 years over six decades, the proportion of life spent in poor or moderate health has remained unchanged, with women spending 25% more of their lives in poor health despite living longer. Dr. Kristy Prouse, chief medical advisor of women's health at Science&Humans, argued that most health-care spending is a timing problem rather than a treatment problem, suggesting employers should invest more in hormone health as part of employee benefits.